| Analysis of immunohistochemical results of the ras oncogene product p21 in myelodysplastic syndromes. | None |
| [Oncoprotein p21-ras expression in epidermoid carcinoma of the laryngopharynx]. | None |
| Expression of ras p21 oncoprotein in normal and neoplastic human endometrium. | None |
| Ribozyme-mediated cleavage of the BCRABL oncogene transcript: in vitro cleavage of RNA and in vivo loss of P210 protein-kinase activity. | None |
| A nickel-binding serpin, pNiXa, induces maturation of Xenopus oocytes and shows synergism with oncogenic ras-p21 protein. | None |
| Carcinogenicity, metabolism and Ki-ras proto-oncogene activation by 7,12-dimethylbenz[a]anthracene in rainbow trout embryos. | None |
| [K-ras oncogene in bronchial cancer. Its current prognostic role and long-term therapeutic perspectives]. | None |
| Comparison of the computed three-dimensional structures of oncogenic forms (bound to GDP) of the ras-gene-encoded p21 protein with the structure of the normal (non-transforming) wild-type protein. | None |
| Use of PCR-PIRA for screening of a point mutation at codon 12 in K-ras oncogene obtained from paraffin embedded tissue sections. | None |
| Inhibition of oncogene-mediated transformation by ectopic expression of p21Waf1 in NIH3T3 cells. | None |
| Immunohistochemical detection of ras p21 oncoprotein in undifferentiated and well-differentiated epithelial carcinomas of the human ovary. | None |
| [The role of p21ras oncoprotein in signal transduction mediated through B cell antigen receptor (BCR)]. | None |
| Electrostatic control of GTP and GDP binding in the oncoprotein p21ras. | None |
| Structural effects of the binding of GTP to the wild-type and oncogenic forms of the ras-gene-encoded p21 proteins. | None |
| Novel anti-carcinogenic activity of an organosulfide from garlic: inhibition of H-RAS oncogene transformed tumor growth in vivo by diallyl disulfide is associated with inhibition of p21H-ras processing. | None |
| Transcriptional activation by p53, but not induction of the p21 gene, is essential for oncogene-mediated apoptosis. | None |
| The v-Ki-Ras oncogene alters cAMP nuclear signaling by regulating the location and the expression of cAMP-dependent protein kinase IIbeta. | None |
| Detection of K-ras oncogene mutations by polymerase chain reaction-based ligase chain reaction. | None |
| Oncogenic amino acid substitutions in the inhibitory rap-1A protein cause it to adopt a ras-p21-like conformation as computed using molecular dynamics. | None |
| Semiautomated sequence-specific mutation detection of the human K-ras oncogene using cold SSCP analysis. | None |